Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3770893016 | Carglumic acid only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3770894010 | Product containing only carglumic acid in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Carglumic acid only product in oral dose form | est un(e) (attribut) | Carglumic acid only product | true | Inferred relationship | Some | ||
| Carglumic acid only product in oral dose form | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Carglumic acid only product in oral dose form | est un(e) (attribut) | Product containing carglumic acid in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Carglumic acid only product in oral dose form | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Carglumic acid only product in oral dose form | a pour principe actif (attribut) | Carglumic acid (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely carglumic acid 200 milligram/1 each tablet for conventional release oral suspension (clinical drug) | est un(e) (attribut) | True | Carglumic acid only product in oral dose form | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR